Stryker Price to Book Ratio 2011-2025 | SYK
Historical price to book ratio values for Stryker (SYK) over the last 10 years. The current price to book ratio for Stryker as of November 12, 2025 is 6.38.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Stryker Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-11-12 | 367.34 | 6.63 | |
| 2025-06-30 | 394.73 | $55.43 | 7.12 |
| 2025-03-31 | 370.61 | $54.78 | 6.77 |
| 2024-12-31 | 357.64 | $54.10 | 6.61 |
| 2024-09-30 | 358.01 | $52.87 | 6.77 |
| 2024-06-30 | 336.44 | $51.88 | 6.48 |
| 2024-03-31 | 353.03 | $50.33 | 7.01 |
| 2023-12-31 | 294.74 | $48.92 | 6.03 |
| 2023-09-30 | 268.24 | $47.13 | 5.69 |
| 2023-06-30 | 298.63 | $45.71 | 6.53 |
| 2023-03-31 | 278.73 | $44.51 | 6.26 |
| 2022-12-31 | 238.08 | $43.88 | 5.43 |
| 2022-09-30 | 196.61 | $43.51 | 4.52 |
| 2022-06-30 | 192.46 | $41.43 | 4.65 |
| 2022-03-31 | 257.74 | $39.78 | 6.48 |
| 2021-12-31 | 257.15 | $39.41 | 6.53 |
| 2021-09-30 | 252.95 | $37.58 | 6.73 |
| 2021-06-30 | 248.53 | $36.65 | 6.78 |
| 2021-03-31 | 232.51 | $35.84 | 6.49 |
| 2020-12-31 | 233.30 | $34.79 | 6.71 |
| 2020-09-30 | 197.87 | $34.56 | 5.73 |
| 2020-06-30 | 170.63 | $33.96 | 5.03 |
| 2020-03-31 | 157.14 | $34.94 | 4.50 |
| 2019-12-31 | 197.43 | $34.20 | 5.77 |
| 2019-09-30 | 202.86 | $32.89 | 6.17 |
| 2019-06-30 | 192.34 | $31.92 | 6.02 |
| 2019-03-31 | 184.32 | $31.28 | 5.89 |
| 2018-12-31 | 145.89 | $31.33 | 4.66 |
| 2018-09-30 | 164.81 | $26.35 | 6.25 |
| 2018-06-30 | 156.21 | $25.29 | 6.18 |
| 2018-03-31 | 148.46 | $24.68 | 6.02 |
| 2017-12-31 | 142.42 | $26.66 | 5.34 |
| 2017-09-30 | 130.24 | $27.87 | 4.67 |
| 2017-06-30 | 126.88 | $26.83 | 4.73 |
| 2017-03-31 | 120.00 | $25.95 | 4.62 |
| 2016-12-31 | 108.85 | $25.49 | 4.27 |
| 2016-09-30 | 105.39 | $24.95 | 4.22 |
| 2016-06-30 | 108.14 | $24.33 | 4.45 |
| 2016-03-31 | 96.50 | $23.55 | 4.10 |
| 2015-12-31 | 83.29 | $22.82 | 3.65 |
| 2015-09-30 | 83.99 | $22.56 | 3.72 |
| 2015-06-30 | 85.00 | $22.56 | 3.77 |
| 2015-03-31 | 81.75 | $22.01 | 3.71 |
| 2014-12-31 | 83.28 | $22.74 | 3.66 |
| 2014-09-30 | 71.04 | $22.81 | 3.11 |
| 2014-06-30 | 73.90 | $23.81 | 3.10 |
| 2014-03-31 | 71.14 | $23.98 | 2.97 |
| 2013-12-31 | 65.37 | $23.93 | 2.73 |
| 2013-09-30 | 58.56 | $23.11 | 2.53 |
| 2013-06-30 | 55.82 | $22.76 | 2.45 |
| 2013-03-31 | 56.08 | $22.37 | 2.51 |
| 2012-12-31 | 46.93 | $22.62 | 2.07 |
| 2012-09-30 | 47.42 | $22.00 | 2.16 |
| 2012-06-30 | 46.76 | $20.87 | 2.24 |
| 2012-03-31 | 46.90 | $21.06 | 2.23 |
| 2011-12-31 | 41.86 | $20.17 | 2.08 |
| 2011-09-30 | 39.52 | $19.73 | 2.00 |
| 2011-06-30 | 49.03 | $20.03 | 2.45 |
| 2011-03-31 | 50.63 | $19.21 | 2.64 |
| 2010-12-31 | 44.59 | $18.35 | 2.43 |
| 2010-09-30 | 41.42 | $18.40 | 2.25 |
| 2010-06-30 | 41.30 | $17.00 | 2.43 |
| 2010-03-31 | 47.07 | $16.82 | 2.80 |
| 2009-12-31 | 41.33 | $16.57 | 2.49 |
| 2009-09-30 | 37.09 | $16.20 | 2.29 |
| 2009-06-30 | 32.44 | $15.24 | 2.13 |
| 2009-03-31 | 27.79 | $14.17 | 1.96 |
| 2008-12-31 | 32.61 | $13.64 | 2.39 |
| 2008-09-30 | 50.35 | $14.23 | 3.54 |
| 2008-06-30 | 50.82 | $15.09 | 3.37 |
| 2008-03-31 | 52.57 | $14.41 | 3.65 |
| 2007-12-31 | 60.39 | $13.09 | 4.61 |
| 2007-09-30 | 55.33 | $12.58 | 4.40 |
| 2007-06-30 | 50.77 | $11.72 | 4.33 |
| 2007-03-31 | 53.37 | $10.97 | 4.86 |
| 2006-12-31 | 44.35 | $10.27 | 4.32 |
| 2006-09-30 | 39.74 | $9.81 | 4.05 |
| 2006-06-30 | 33.75 | $9.27 | 3.64 |
| 2006-03-31 | 35.54 | $8.59 | 4.14 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $139.087B | $22.595B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $220.837B | 25.45 |
| EssilorLuxottica (ESLOY) | France | $169.692B | 0.00 |
| Boston Scientific (BSX) | United States | $151.950B | 34.75 |
| Medtronic (MDT) | Ireland | $122.368B | 17.25 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.739B | 0.00 |
| Agilent Technologies (A) | United States | $42.361B | 27.42 |
| ResMed (RMD) | United States | $36.840B | 25.50 |
| GE HealthCare Technologies (GEHC) | United States | $33.440B | 15.99 |
| Koninklijke Philips (PHG) | Netherlands | $28.242B | 18.45 |
| Terumo (TRUMY) | Japan | $24.252B | 28.74 |
| Insulet (PODD) | United States | $22.953B | 71.24 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.539B | 10.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.204B | 0.00 |
| Baxter (BAX) | United States | $9.382B | 7.57 |
| Sunny Optical Technology (SNPTF) | China | $9.339B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.452B | 30.39 |
| Demant (WILYY) | Denmark | $7.496B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.539B | 10.78 |
| ICU Medical (ICUI) | United States | $3.536B | 22.45 |
| Haemonetics (HAE) | United States | $3.358B | 14.94 |
| Envista Holdings (NVST) | United States | $3.323B | 19.07 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.913B | 13.28 |
| LeMaitre Vascular (LMAT) | United States | $2.050B | 41.26 |
| Perrigo (PRGO) | Ireland | $1.968B | 4.93 |
| Curaleaf Holdings (CURLF) | Canada | $1.896B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.837B | 18.35 |
| AtriCure (ATRC) | United States | $1.634B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.504B | 65.91 |
| QuidelOrtho (QDEL) | United States | $1.487B | 9.56 |
| Tilray Brands (TLRY) | Canada | $1.448B | 0.00 |
| Neogen (NEOG) | United States | $1.419B | 27.21 |
| Kestra Medical Technologies (KMTS) | United States | $1.418B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.291B | 18.71 |
| BioLife Solutions (BLFS) | United States | $1.254B | 372.00 |
| InMode (INMD) | Israel | $0.917B | 10.36 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.830B | 0.00 |
| Valneva SE (VALN) | France | $0.764B | 0.00 |
| Surmodics (SRDX) | United States | $0.585B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.517B | 17.80 |
| SNDL (SNDL) | Canada | $0.486B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.481B | 0.00 |
| Omeros (OMER) | United States | $0.469B | 0.00 |
| CeriBell (CBLL) | United States | $0.464B | 0.00 |
| Evolus (EOLS) | United States | $0.453B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.431B | 0.00 |
| Cerus (CERS) | United States | $0.317B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.303B | 0.00 |
| Brainsway (BWAY) | Israel | $0.288B | 50.60 |
| Canopy Growth (CGC) | Canada | $0.288B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.286B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.283B | 0.00 |
| High Tide (HITI) | Canada | $0.261B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.256B | 151.67 |
| Sanara MedTech (SMTI) | United States | $0.250B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.241B | 19.24 |
| Quanterix (QTRX) | United States | $0.234B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.224B | 0.00 |
| Organigram Global (OGI) | Canada | $0.221B | 0.00 |
| Owens & Minor (OMI) | United States | $0.220B | 2.21 |
| TriSalus Life Sciences (TLSI) | United States | $0.216B | 0.00 |
| Exagen (XGN) | United States | $0.209B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.195B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 16.16 |
| FitLife Brands (FTLF) | United States | $0.180B | 22.17 |
| OraSure Technologies (OSUR) | United States | $0.176B | 0.00 |
| Apyx Medical (APYX) | United States | $0.153B | 0.00 |
| Biote (BTMD) | United States | $0.129B | 5.21 |
| Jushi Holdings (JUSHF) | United States | $0.128B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.103B | 0.00 |
| Sharps Technology (STSS) | United States | $0.103B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.099B | 0.00 |
| MacroGenics (MGNX) | United States | $0.096B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 13.33 |
| Agape ATP (ATPC) | $0.065B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.057B | 33.00 |
| Nephros (NEPH) | United States | $0.046B | 33.31 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Jin Medical (ZJYL) | China | $0.039B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Zynex (ZYXI) | United States | $0.035B | 0.00 |
| Bonk (BNKK) | United States | $0.033B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.77 |
| Modular Medical (MODD) | United States | $0.027B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| INLIF (INLF) | China | $0.010B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |